3′-5′ Phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo

Por Toledano, Elie, Ogryzko, Vasily, Danchin, Antoine, Ladant, Daniel, Mechold, Undine
Publicado em 2012

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti—NMDA-receptor autoantibody

Por Gréa, Hélène, Scheid, Isabelle, Gaman, Alexandru, Rogemond, Véronique, Gillet, Sandy, Honnorat, Jérôme, Bolognani, Federico, Czech, Christian, Bouquet, Céline, Toledano, Elie, Bouvard, Manuel, Delorme, Richard, Groc, Laurent, Leboyer, Marion
Publicado no Dialogues Clin Neurosci (2017)

Cerebellar anatomical alterations and attention to eyes in autism

Por Laidi, Charles, Boisgontier, Jennifer, Chakravarty, M. Mallar, Hotier, Sevan, d’Albis, Marc-Antoine, Mangin, Jean-François, Devenyi, Gabriel A., Delorme, Richard, Bolognani, Federico, Czech, Christian, Bouquet, Céline, Toledano, Elie, Bouvard, Manuel, Gras, Doriane, Petit, Julie, Mishchenko, Marina, Gaman, Alexandru, Scheid, Isabelle, Leboyer, Marion, Zalla, Tiziana, Houenou, Josselin
Publicado no Sci Rep (2017)